We welcome the new ESO Executive Committee. Congratulations to @FishingNeurons as President & Robin Lemmens as President-Elect. A warm welcome to new members @HanneKChr & Pierre Seners.
We extend our thanks to @Simona_Sacco_ for her leadership during her term as ESO President.
🧵1/6 Exciting results from the #TECNO trial presented at @ESOstroke in Maastricht 🇳🇱
Despite successful thrombectomy, up to ~40% of patients have incomplete reperfusion (TICI <3) and worse outcomes.
Can administering intra-arterial thrombolysis after EVT help❓️
#ESOC2026
We welcome the new ESO Executive Committee. Congratulations to @FishingNeurons as President & Robin Lemmens as President-Elect. A warm welcome to new members @HanneKChr & Pierre Seners.
We extend our thanks to @Simona_Sacco_ for her leadership during her term as ESO President.
Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial - The Lancet Neurology thelancet.com/journals/laneu…
Excellent investigators meeting of our @DOIT_trial at ESOC2026! The room was fully packed and many people were online. Congratulations to Thomas Meinel and Luciana Catanese for the amazing leadership!
TECNO trial: Intra-arterial Tenecteplase after incomplete thrombectomy is safe but doesn’t significantly improve reperfusion or outcomes vs standard care. More research needed to refine patient selection and treatment strategies in stroke care.
#ESOC2026#VoiceOfStroke#Stroke
Among survivors of intracerebral hemorrhage, a single pill with three low-dose antihypertensive agents added to standard care was associated with a lower incidence of stroke and major cardiovascular events than placebo. Full TRIDENT trial results: nejm.org/doi/full/10.1056/NE…
Editorial: Blood-Pressure Control after Intracerebral Hemorrhage — An Unbroken Glass Ceiling nejm.org/doi/full/10.1056/NE…
ALT Original Article | APR 23, 2026
Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage (TRIDENT)
Figure 2. Cumulative Incidence of First Recurrent Stroke (Primary Outcome).
Among survivors of intracerebral hemorrhage, a single pill with three low-dose antihypertensive agents added to standard care was associated with a lower incidence of stroke and major cardiovascular events than placebo. Full TRIDENT trial results: nejm.org/doi/full/10.1056/NE…
Editorial: Blood-Pressure Control after Intracerebral Hemorrhage — An Unbroken Glass Ceiling nejm.org/doi/full/10.1056/NE…
ALT Original Article | APR 23, 2026
Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage (TRIDENT)
Figure 2. Cumulative Incidence of First Recurrent Stroke (Primary Outcome).
Stroke is a global challenge. Education is key to fight the global burden of stroke! The first Latin American Stroke Summer School trains the next generation of physicians in South America. Thank you Sheila Martins to help to launch this joint endeavor! instagram.com/reel/DRxUs-ygJ…